NCT07232654 2025-12-01
Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
University of California, San Diego
Tata Memorial Centre
Tongji Hospital
Sichuan Cancer Hospital and Research Institute
Zhejiang Cancer Hospital
University of Erlangen-Nürnberg Medical School